A Study reports that HT patients exhibit fewer IDO+ plasmacytoid dendritic cells (pDCs), elevated serum Trp, a reduced Kyn/Trp ratio, and heightened in vitro IFN-α responses (8). Here, IDO1 is linked to hematocrit.